epilepsy | cpnp.org

Home
About CPNP
- Why Join CPNP
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Awards
- CPNP Foundation
- Corporate Sponsorships
  - Sponsor Program
  - Sponsors
- Information for Patients
- Contact CPNP
Education
- April 2013 Annual Meeting in Colorado Springs, CO
- April 2014 Annual Meeting in Phoenix, AZ
- CPNP University Online Courses
- Drug-Induced Movement Disorders Training DVD
- Psychiatric Pharmacotherapy for Nurses
- Other Meetings
- Find More Resources in My CPNP
  - My CPNP Presentations & Exams
  - My CPNP ACPE Transcript Center
BCPP
- BCPP Exam Preparation
  - BCPP Exam Preparation
  - Certification FAQ
- BCPP Recertification
Careers/Residencies
Member Center
- Member Toolkit
- Email List
- Member Directory
- CPNP Documents and Reports
- Member Hubs
  - Pharmacy Student Hub
  - New Practitioner Hub
Resources
Gov't and Prof Affairs
- Comprehensive Medication Management
- Government Affairs
  - Contacting Legislators and Policy Makers
  - Medicare Coverage Initiative with ACCP
- Position/White Papers
  - Psychiatric Pharmacy Manifesto
  - Psychiatric Pharmacist Integration into the Medical Home Model
My CPNP
- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities

epilepsy

Vagus nerve stimulation: a new tool for brain research and therapy.

George MS, Sackeim HA, Rush AJ, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000;47(4):287-95. Available at: .

A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.

McVearry KM, Gaillard WD, VanMeter J, Meador KJ. A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav. 2009;16(4):609-16. doi:10.1016/j.yebeh.2009.09.024.

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77(2):193-8. doi:10.1136/jnnp.2005.074203.

Levetiracetam use in pregnancy.

Longo B, Forinash AB, Murphy JA. Levetiracetam use in pregnancy. Ann Pharmacother. 2009;43(10):1692-5. doi:10.1345/aph.1M231.

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.

Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology. 2006;67(10):1876-9. doi:10.1212/01.wnl.0000244491.48937.55.

A North American Registry for Epilepsy and Pregnancy, a unique public/private partnership of health surveillance.

Anon. A North American Registry for Epilepsy and Pregnancy, a unique public/private partnership of health surveillance. Epilepsia. 1998;39(7):793-8. Available at: .

A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.

Kim W-J, Lee JH, Yi J, et al. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genomics. 2010;20(4):249-56. doi:10.1097/FPC.0b013e328338073a.

Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects.

Zaccara G, Campostrini R, Paganini M, et al. Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects. Ther Drug Monit. 1987;9(1):34-40. Available at: .

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16(10):695-714. Available at: .

Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.

Rinnerthaler M, Luef G, Mueller J, et al. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate. Epilepsia. 2005;46(2):320-3. doi:10.1111/j.0013-9580.2005.36204.x.